The COVID-19 Monitoring and Assessment Program (MAP) ended on June 30, 2023 and the last day of operation was June 22.
For questions or to request results until July 31st, email firstname.lastname@example.org. This email is monitored Monday-Friday.
MAP was created in spring 2020 to develop and expand the university’s testing capacity for the coronavirus that causes COVID-19.
The program leveraged the research strengths of the UO, including experts in genomics, data science, prevention science, and other areas.
MAP Tests Provided
Develop a fully operational clinical laboratory improvement amendments (CLIA)-certified testing laboratory on campus.
Create test collection and test processing systems to provide capacity for screening and surveillance testing for COVID-19 at UO and its surrounding community.
Use the results of the testing to develop strategies that local officials and university leaders can enact to reduce the spread of COVID-19 as activity and population changes occur.
Sample Collection Methods
- Self-collected saliva—in use
- Self-collected shallow nasal swab (anterior nares)—in use
- Deep nasal swab—approved, but not in use
Sample Processing Methods
DiaCarta QuantiVirus SARS-CoV-2 quantitative PCR (qPCR) – in use
Genotyping by RNA sequencing, and high throughput RNA-seq of entire viral genomes—in use
Saliva Direct—in use
SwabSeq—optimized but not in use